参考文献/References:
[1]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J].中华心血管病杂志,2017,45(5):359-376. [2]刘群,赵冬,刘军,等.中国ST段抬高急性冠状动脉综合征诊疗现况调查[J].中华心血管病杂志,2009,37(03):213-217. [3]方芳,张伟,乔旭柏,等.急性冠状动脉综合征患者易损斑块的临床病理分析[J].中华心血管病杂志,2011,39(09):802-806. [4]丁士芳,张运,张梅,等.斑块稳定性与炎症反应在急性冠状动脉综合征中作用的研究[J].中华心血管病杂志,2006,34(06):512-514. [5]肖智谦,龙运玲,彭湘南,等.不稳定心绞痛患者血hsCRP、P选择素水平与近期预后关系[J].心血管病防治知识,2018,4(5):19-21. [6]马建林,马立宁,张银环,等.不稳定型心绞痛合并高血压病患者血浆P-选择素和血小板变化的研究[J].中国医药,2014,9(2):145-148. [7]刘芳.老年急性冠脉综合征患者氨基末端脑钠肽前体、血小板P选择素、超敏C反应蛋白检测及对预后的影响[J].中西医结合心脑血管病杂志,2013,11(9):1062-1063. [8]肖智谦,龙运玲,彭湘南,等.P-选择素水平对不稳定心绞痛患者MACE发生率的影响[J].广西医科大学学报,2018,35(5):693-695. [9]杨礼,黄怡,罗立,等.P-选择素、高敏C反应蛋白与急性冠状动脉综合征发病的相关性研究[J].中国现代医学杂志,2014,24(8):91-93. [10]Khan SQ,Dhillon O,Kelly D,et al.Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction:comparison with plasma midregional pro-atrial natriuretic peptide:the LAMP(Leicester Acute Myocardial Infarction Peptide)study[J].J Am Coll Cardiol,2008,51(19):1857-1864. [11]刘子源,刘帅,张艳丽,等.sST2、NT-proBNP及sCD40L在急性冠脉综合征危险分层及预后评估中的临床意义[J].中西医结合心脑血管病杂志,2016,14(2):180-182. [12]Rahman MM,Alam MM,Jahan NA,et al.Prognostic Role of Multiple Cardiac Biomarkers in Newly Diagnosed Acute Coronary Syndrome Patients[J].Mymensingh Med J,2016,25(2):326-333. [13]孙艺红,王桂莲,傅媛媛,等.床旁B型利钠肽检测与全球急性冠状动脉事件注册评分对急性冠状动脉综合征患者的预后价值[J].中华心血管病杂志,2009,37(08):716-720. [14]刘文娴,赵晗.非ST段抬高急性冠状动脉综合征患者血浆N末端B型利钠肽原与GRACE评分的相关研究[J].中华心血管病杂志,2012,40(05):373-377. [15]Afsar CU,Uzun H,Yurdakul S,et al.Association of serum fetuin-A levels with heart valve calcification and other biomarkers of inflammation among persons with acute coronary syndrome[J].Clin Invest Med,2012,35(4):E206-E215. [16]Lim P,Moutereau S,Simon T,et al.Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes(from the French Registry of Acute ST-Elevation Non ST-Elevation Myocardial Infarction [FAST MI])[J].Am J Cardiol,2013,111(1):31-37. [17]Lillpopp L,Tzikas S,Ojeda F,et al.Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome[J].Am J Cardiol,2012,110(9):1225-1230. [18]Meune C,Wahbi K,Weber S,et al.Performance of glycogen phosphorylase isoenzyme BB is weak in the detection of patients with non-ST-elevation acute coronary syndrome[J].Clin Biochem,2011,44(16):1343-1345. [19]Bozkurt S,Kaya EB,Okutucu S,et al.The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome[J].Cardiol J,2011,18(5):496-502. [20]Chalikias GK,Tziakas DN,Kaski JC,et al.Interleukin-18/interleikin-10 ratio is an independent predictor of recurrent coronary events during a 1-Year follow up in patents with acute coronary syndrome[J].Int J Cardiol,2007,117(3):333-339. [21]李巧汶,邱健,马骏,等.急性冠脉综合征患者血浆白介素18,白介素10及其比值的变化和意义[J].中国误诊学杂志,2008,8(14):3282-3284.
相似文献/References:
[1]廖丽萍,周跟东,张晓红.TyG指数对急诊PCI术后ACS患者预后的预测价值[J].医学信息,2021,34(04):123.[doi:10.3969/j.issn.1006-1959.2021.04.032]
LIAO Li-ping,ZHOU Gen-dong,ZHANG Xiao-hong.The Predictive Value of TyG Index on the Prognosis of ACS Patients After Emergency PCI Surgery[J].Medical Information,2021,34(20):123.[doi:10.3969/j.issn.1006-1959.2021.04.032]
[2]任智慧.血清BNP、cTNⅠ及hs-CRP联合检查在急性冠脉综合征危险分层中的意义[J].医学信息,2021,34(05):127.[doi:10.3969/j.issn.1006-1959.2021.05.036]
REN Zhi-hui.Significance of Combined Examination of Serum BNP,cTNⅠ and hs-CRP in Risk Stratification of Acute Coronary Syndrome[J].Medical Information,2021,34(20):127.[doi:10.3969/j.issn.1006-1959.2021.05.036]
[3]刘纲毅,谢妹珍,李丽敏,等.床旁检测心脏型脂肪酸结合蛋白和肌钙蛋白I在急性冠状动脉综合征中的价值[J].医学信息,2021,34(12):93.[doi:10.3969/j.issn.1006-1959.2021.12.024]
LIU Gang-yi,XIE Mei-zhen,LI Li-min,et al.The Value of Bedside Detection of Cardiac Fatty Acid Binding Protein and Troponin I in Acute Coronary Syndrome[J].Medical Information,2021,34(20):93.[doi:10.3969/j.issn.1006-1959.2021.12.024]